Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naive individuals: a systematic review of detection methods, prevalence, and clinical impact

HA Mbunkah, S Bertagnolio, RL Hamers… - The Journal of …, 2020 - academic.oup.com
Background The presence of high-abundance drug-resistant HIV-1 jeopardizes success of
antiretroviral therapy (ART). Despite numerous investigations, the clinical impact of low …

[PDF][PDF] Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naïve individuals: A systematic review of detection methods, prevalence, and clinical impact.

HA Mbunkah, S Bertagnolio, RL Hamers, G Hunt… - 2019 - researchgate.net
We systematically assessed 103 studies on the prevalence of low-abundance drug-resistant
HIV-1 variants and their impact on antiretroviral therapy, which remains uncertain. Important …

[HTML][HTML] Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical …

HA Mbunkah, S Bertagnolio, RL Hamers… - The Journal of …, 2020 - ncbi.nlm.nih.gov
Background The presence of high-abundance drug-resistant HIV-1 jeopardizes success of
antiretroviral therapy (ART). Despite numerous investigations, the clinical impact of low …

Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A systematic review of detection methods, prevalence, and clinical impact

HA Mbunkah, S Bertagnolio… - Journal of …, 2020 - researchinformation.amsterdamumc …
Background: The presence of high-abundance drug-resistant HIV-1 jeopardizes success of
antiretroviral therapy (ART). Despite numerous investigations, the clinical impact of low …

Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical Impact.

HA Mbunkah, S Bertagnolio, RL Hamers… - The Journal of …, 2020 - folia.unifr.ch
METHODS We systematically reviewed 103 studies assessing prevalence, detection
methods, technical and clinical detection cutoffs, and clinical significance of LA-DRVs in …

Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naïve individuals: A systematic review of detection methods, prevalence, and clinical impact

HA Mbunkah, S Bertagnolio, RL Hamers… - Journal of Infectious …, 2020 - zora.uzh.ch
BACKGROUND The presence of high-abundance drug-resistant HIV-1 jeopardizes the
success of antiretroviral therapy (ART). Despite numerous investigations, the clinical impact …

Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical Impact.

HA Mbunkah, S Bertagnolio, RL Hamers… - The Journal of …, 2020 - europepmc.org
Background The presence of high-abundance drug-resistant HIV-1 jeopardizes success of
antiretroviral therapy (ART). Despite numerous investigations, the clinical impact of low …

Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naive individuals: a systematic review of detection methods, prevalence, and clinical impact.

HA Mbunkah, S Bertagnolio, RL Hamers, G Hunt… - 2020 - cabidigitallibrary.org
Background: The presence of high-abundance drug-resistant HIV-1 jeopardizes success of
antiretroviral therapy (ART). Despite numerous investigations, the clinical impact of low …

Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical Impact.

HA Mbunkah, S Bertagnolio, RL Hamers… - The Journal of infectious …, 2020 - sonar.ch
METHODS We systematically reviewed 103 studies assessing prevalence, detection
methods, technical and clinical detection cutoffs, and clinical significance of LA-DRVs in …

Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical Impact

HA Mbunkah, S Bertagnolio, RL Hamers… - The Journal of …, 2020 - academic.oup.com
Background The presence of high-abundance drug-resistant HIV-1 jeopardizes success of
antiretroviral therapy (ART). Despite numerous investigations, the clinical impact of low …